This functionality is implemented using Javascript. It cannot work without it, etc...

We are loading the information...

Skip to main content

Medical Policies

Medical policies are documents that define the plan coverage for technologies, procedures and treatments. The statements of medical necessity in the policies, about whether a technology, procedure, treatment, supply, equipment, drug or other service improves the health outcome of the population for which said technology or treatment was designed are based on scientific evidence, clinical studies and professional opinions from our providers and recognized medical organizations.

Each document displayed on this website is provided for informational purposes only and is not an authorization, explanation of benefits, or contract. Receiving benefits is subject to satisfaction of all terms and conditions of coverage. Medical technology is constantly changing, and we reserve the right to periodically review and update our policies.

ID Title Last Review Next Review Description Access
11.001.036 Quantitative Assay For Measurement Of Her2 Total Protein Expression And Her2 Jan 19, 2021 Policy Archived Novel assays that quantitatively measure total human epidermal growth factor receptor 2 (her2) protein... View
11.001.037 Intracellular Micronutrient Analysis Jan 08, 2025 Jan 20, 2026 Commercial laboratories offer panels of tests evaluating intracellular levels of micronutrients (essential... View
11.001.038 Multitarget Polymerase Chain Traction Testing For Diagnosis Of Bacterial Vaginosis Jan 15, 2025 Policy Archived Bacterial vaginosis (bv) is a common medical condition resulting from an imbalance in the normal vaginal... View
11.001.039 Nutrient/Nutritional Panel Testing Jan 15, 2025 Jan 20, 2026 Multimarker nutritional panel testing is proposed for patients with certain chronic conditions (eg, mood... View
11.001.040 Testing Serum Vitamin D Levels Jan 15, 2025 Jan 20, 2026 Vitamin d, also known as calciferol, is a fat-soluble vitamin that has a variety of physiologic effects, most... View
11.001.041 Drug Testing In Pain Management And Substance Use Disorder Treatment Dec 09, 2024 Dec 20, 2025 Patients in pain management programs and substance use disorder treatment may misuse prescribed opioids... View
11.001.042 Fecal Calprotectin Testing Jun 13, 2025 Jan 20, 2026 Calprotectin is a calcium- and zinc-binding protein that is a potential marker of intestinal inflammation.... View
11.001.044 Antigen Leukocyte Antibody Test Nov 15, 2024 Nov 20, 2025 The antigen leukocyte antibody test (alcat) is intended to diagnose intolerance to foods and other... View
11.001.046 Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes Mar 20, 2025 Mar 20, 2026 Improved accuracy of the identification of pregnant people at risk of preeclampsia and spontaneous preterm... View
11.001.047 Multicancer Early Detection Testing Jul 19, 2024 Jul 20, 2025 Many cancers appear to have a better prognosis if diagnosed early in their natural history. this has led to... View
11.002.001 Systems Pathology In Prostate Cancer Dec 10, 2020 Policy Archived Systems pathology, an approach that combines cellular and biologic features to standard clinical parameters,... View
11.002.003 Molecular Testing For The Management Of Pancreatic Cysts, Barrett Esophagus, And Solid Pancreaticobiliary Lesions Dec 26, 2024 Dec 20, 2025 Tests that integrate microscopic analysis with molecular tissue analysis are generally called topographic... View
11.002.004 Cervical Cancer Screening Technologies With Pap And Hpv Apr 28, 2022 Policy Archived Data suggest that cytologic screening for cervical cancer reduces the incidence of cervical cancer by up to... View
11.003.001 Laboratory Tests For Heart And Kidney Transplant Rejection Nov 15, 2024 Nov 20, 2025 Clinical assessment and noninvasive imaging of chronic heart failure can be limited in accurately diagnosing... View
11.003.002 Genetic Testing For Predisposition To Inherited Hypertrophic Cardiomyopathy Apr 18, 2025 Apr 20, 2026 Familial hypertrophic cardiomyopathy is an inherited condition caused by a disease associated variant in 1 or... View
11.003.003 Multimarker Serum Testing Related To Ovarian Cancer Jan 20, 2025 Jan 20, 2026 A variety of serum biomarkers have been studied for their association with ovarian cancer. of particular... View
11.003.004 Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Metastatic Colorectal Cancer (KRAS, NRAS, BRAF, MMR/MSI, HER2, and TMB) Aug 23, 2024 Aug 20, 2025 Summary the epidermal growth factor receptor (egfr) is overexpressed in colorectal cancer (crc).... View
11.003.006 Pruebas Genéticas para el Tratamiento Helico Bacter Pylori May 12, 2016 Policy Archived ... View
11.003.008 Cytochrome P450 Genotype-Guided Treatment Strategy Jul 17, 2024 Jul 20, 2025 The cytochrome p450 (cyp450) family is involved in the metabolism of many currently administered drugs, and... View
11.003.009 Molecular Analysis For Targeted Therapy Of Non-Small-Cell Lung Cancer Dec 05, 2024 Dec 20, 2025 Over half of patients with non-small-cell lung cancer (nsclc) present with advanced and therefore incurable... View
787-277-6653 787-474-6326